Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
60. Lisdexamfetamine for methamphetamine use disorder
60. Lisdexamfetamine for methamphetamine use disorder
60. Lisdexamfetamine for methamphetamine use disorder
Monday 26th May 2025
Explore lisdexamfetamine's role in treating methamphetamine dependence with expert insights from Addiction Medicine Journal Club.
43 minutes
Informative
Engaging
Compassionate
Educational
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
72 (View all)
Do you want to link to this podcast?
Get the buttons here!Can Lisdexamfetamine Help Treat Methamphetamine Use Disorder?
Episode Overview
- Lisdexamfetamine trial showed mixed results for methamphetamine dependence.
- Exploration of genetic factors affecting hangover experiences.
- Discussion on tianeptine's addictive properties.
- Challenges in addiction medicine during COVID-19.
- Potential benefits and limitations of using stimulants for addiction treatment.
"It's interesting that they're all like opioid-like products sliding through – basically backdoor opioid use disorder."
If you've ever wondered whether stimulants could help treat methamphetamine use disorder, this episode of Addiction Medicine Journal Club might just pique your curiosity. Hosts Dr. Sonya Del Tredici and Dr. John Keenan dive into a fascinating discussion about lisdexamfetamine, commonly known as Vyvanse, and its potential in tackling methamphetamine dependence. With a randomised, placebo-controlled trial at the heart of their conversation, the hosts explore the ups and downs of using this stimulant as a treatment option.
The study involved 164 participants and aimed to see if lisdexamfetamine could reduce methamphetamine use while being safe for those with the disorder. Beyond the science, there's plenty of lively banter between Sonya and John, making complex topics more digestible and even entertaining. They don't shy away from discussing the peculiarities of hangovers or the dangers of tianeptine, dubbed 'gas station heroin'.
The episode is not just about data – it's about understanding the nuances of addiction medicine and the challenges faced by practitioners. So, why should you tune in? Whether you're a healthcare professional seeking insights into addiction treatment or someone curious about the latest developments in addiction medicine, this episode offers a comprehensive look at a potential new treatment path. It's packed with expert opinions, real-world anecdotes, and a touch of humour to keep things engaging.
Don't miss out on the chance to expand your knowledge and maybe even find some answers to questions you've been pondering.